In a landmark clinical trial that may redefine prenatal care for at-risk pregnancies, researchers have presented compelling evidence supporting the use of antenatal N-acetylcysteine (NAC) supplementation in pregnant women facing imminent preterm birth. This prospective randomized
NAC N-acetyl cysteine
